Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 9, 2004, Pages 4280-4284

  Kumagai, Atsushi ^a,b   Namba, Hiroyuki ^a,g   Saenko, Vladimir A ^a   Ashizawa, Kiyoto ^a   Ohtsuru, Akira ^b   Ito, Masahiro ^c   Ishikawa, Naofumi ^d   Sugino, Kiminori ^d   Ito, Koichi ^d   Jeremiah, Stephen ^e   Thomas, Geraldine A ^e   Bogdanova, Tatyana I ^f   Tronko, Mykola D ^f   Nagayasu, Takeshi ^b   Shibata, Yoshisada ^a   Yamashita, Shunichi ^a,b  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^d ITO HOSPITAL   (Japan)

^e SINGLETON HOSPITAL   (United Kingdom)

^f STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

^g NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; RAF PROTEIN; UNCLASSIFIED DRUG; BRAF PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN RET; PROTEIN TYROSINE KINASE; RET PROTEIN, HUMAN;

ADOLESCENT; ADULT; ADULT DISEASE; CHERNOBYL ACCIDENT; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; MALE; MUTATION RATE; ONCOGENE RAS; ONCOGENE RET; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; REVIEW; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA; ARTICLE; ELECTRIC POWER PLANT; GENETICS; INFANT; MUTATION; PAPILLARY CARCINOMA; PRESCHOOL CHILD; RADIATION ACCIDENT; THYROID TUMOR; UKRAINE;

ACCIDENTS, RADIATION; ADOLESCENT; CARCINOMA, PAPILLARY; CHILD; CHILD, PRESCHOOL; FEMALE; GENE REARRANGEMENT; HUMANS; INFANT; MALE; MUTATION; ONCOGENE PROTEINS; POWER PLANTS; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS; UKRAINE;

EID: 4544314992     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0172     Document Type: Review

References (24)

1. Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, Beller U, Westra WH, Ladenson PW, Sidransky D 2003 BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95:625-627
2. Fukushima T, Suzuki S, Mashiko M, Ohtake T, Endo Y, Takebayashi Y, Sekikawa K, Hagiwara K, Takenoshita S 2003 BRAF mutations in papillary carcinomas of the thyroid. Oncogene 22:6455-6457
3. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA 2003 High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63:1454-1457
4. Namba H, Nakashima M, Hayashi T, Hayashida N, Maeda S, Rogounovitch TI, Ohtsuru A, Saenko VA, Kanematsu T, Yamashita S 2003 Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. J Clin Endocrinol Metab 88:4393-4397
5. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE 2003 BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399-5404
6. Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Maximo V, Botelho T, Seruca R, Sobrinho-Simoes M 2003 BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22:4578-4580
7. Xu X, Quiros RM, Gattuso P, Ain KB, Prinz RA 2003 High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Cancer Res 63:4561-4567
8. Wiersinga WM 2001 Thyroid cancer in children and adolescents: consequences in later life. J Pediatr Endocrinol Metab 14(Suppl 5):1289-1298
9. Hedinger C, Williams ED, Sobin LH 1989 The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908-911
10. Thomas GA, Williams ED, Becker DV, Bogdanova TI, Demidchik EP, Lushnikov E, Nagataki S, Ostapenko V, Pinchera A, Souchkevitch G, Tronko MD, Tsyb AF, Tuttle M, Yamashita S 2001 Creation of a tumour bank for post Chernobyl thyroid cancer. Clin Endocrinol (Oxf) 55:423
11. Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn II GW, Tallini G, Kroll TG, Nikiforov YE 2003 RAS point mutations and PAX8-PPARγ rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88:2318-2326
12. Mai KT, Ford JC, Yazdi HM, Perkins DG, Commons AS 2000 Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules. Pathol Res Pract 196:533-540
13. Santoro M, Thomas GA, Vecchio G, Williams GH, Fusco A, Chiappetta G, Pozcharskaya V, Bogdanova TI, Demidchik EP, Cherstvoy ED, Voscoboinik L, Tronko MD, Carss A, Bunnell H, Tonnachera M, Parma J, Dumont JE, Keller G, Höfler H, Williams ED 2000 Gene rearrangement and Chernobyl related thyroid cancers. Br J Cancer 82:315-322
14. 13a. Unger K, Zitzelsberger H, Salvatore G, Santoro M, Bogdanova T, Braselmann H, Kastner P, Zurnadzhy L, Tronko N, Hutzler P, Thomas G, 2004 Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. J Clin Endocrinol Metab 89:4272-4279
15. Matsuura K, Ogata T, Araki K, Kaneko A, Kobayashi M, Sugimoto T 1997 Thyroid cancer in children: report of three cases and a review of the Japanese literature. Surg Today 27:961-965
16. Shirahige Y, Ito M, Ashizawa K, Motomura T, Yokoyama N, Namba H, Fukata S, Yokozawa T, Ishikawa N, Mimura T, Yamashita S, Sekine I, Kuma K, Ito K, Nagataki S 1998 Childhood thyroid cancer: comparison of Japan and Belarus. Endocr J 45:203-209
17. Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA 1997 Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 57:1690-1694
18. Rabes HM 2001 Gene rearrangements in radiation-induced thyroid carcinogenesis. Med Pediatr Oncol 36:574-582
19. Pacini F, Vorontsova T, Molinaro E, Shavrova E, Agate L, Kuchinskaya E, Elisei R, Demidchik EP, Pinchera A 1999 Thyroid consequences of the Chernobyl nuclear accident. Acta Paediatr 88(Suppl):23-27
20. Fenton C, Anderson J, Lukes Y, Dinauer CA, Tuttle RM, Francis GL 1999 Ras mutations are uncommon in sporadic thyroid cancer in children and young adults. J Endocrinol Invest 22:781-789
21. Motomura T, Nikiforov YE, Namba H, Ashizawa K, Nagataki S, Yamashita S, Fagin JA 1998 ret rearrangements in Japanese pediatric and adult papillary thyroid cancers. Thyroid 8:485-489
22. Bongarzone I, Fugazzola L, Vigneri P, Mariani L, Mondellini P, Pacini F, Basolo F, Pinchera A, Pilotti S, Pierotti MA 1996 Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. J Clin Endocrinol Metab 81:2006-2009
23. Fenton CL, Lukes Y, Nicholson D, Dinauer CA, Francis GL, Tuttle RM 2000 The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. J Clin Endocrinol Metab 85:1170-1175
24. Schroder S, Schwarz W, Rehpenning W, Loning T, Bocker W 1987 Prognostic significance of Leu-M1 immunostaining in papillary carcinomas of the thyroid gland. Virchows Arch A Pathol Anat Histopathol 411:435-439